Experience:
5+ years of experience
Concerned about your lack of experience? Learn More...
Employment Type:
Full time
Posted:
8/23/2017
Job Category:
Research
See more jobs for students and recent grads who studied:
Clinical Program Data Manager
Biogen | Cambridge, Massachusetts
Tell Us More About Your Job Preferences
By telling us what you think of this job, we can help find jobs that match your interests. If you want to see more jobs like this, click on the smiley face. Or if this job isn't what you are looking for, click the frowny face. Learn More...

Follow This Company
Share

Job Description

External Posting TitleClinical Program Data Manager
Job DescriptionThe Data Management Team provides program and project oversight of outsourced clinical trials and is part of the Global Biometrics department, which consists of Data Management, Biostatistics and Statistical Programming. The Program Data and Analytics Lead ensures consistent application of Clinical Data Management operational decisions, facilitates development of program data standards and process within a program or group of studies, and is recognized as an operational specialist in clinical data flow and study execution by all functions across Global Development. Partners with key program and study team members to facilitate implementation of a robust and clear data strategy plan for studies within assigned program. Uses program, phase, TA and operational knowledge to establish study level operational plans and works with DM leads at CROs and other vendors to ensure timely execution. Develops program/study level quality plans to ensure alignment of study operational plans with program goals.

Responsibilities:


• Develops program timeline and monitors data deliverables for all studies within assigned program in collaboration with cross functional team members and vendors

• Develops/Interprets and applies data strategy, verifies consistency and usage of data standards

• Coordinates and oversees outsourced personnel, and monitors and reports on overall study/program progress. Accountable for overall quality of study data

• Develops data integrity, risk mitigation and action plans and oversees execution when appropriate

• Serves as a contact representing DM within Biometrics and clinical study management teams (SMT and/or Clinical Development Team representatives). Liaises directly with internal customers (Biometrics functions, GCO, Regulatory Affairs, Clinical Development Team) and external customers (Full Service and Functional Service Provider Data Leads and Project Management personnel)

• Serves as Subject Matter Expert alongside Biometrics counterparts for data, reporting, and analysis process definition, improvement, and innovation as needed

• Develops, maintains and presents Program Overview to educate team members and vendors

• Regularly provides portfolio status updates to leadership

• Manages performance and quality issues with vendors and escalates to vendor managers and Management and develops appropriate risk mitigation as needed

• Support study-level audit and inspection readiness activities as needed

• Serve as project manager on special projects and initiatives; partners with Statistical Programming, VM and Quality depending on type of project

*LI-RD2
LocationCambridge, MA, US
Job CategoryBiometrics
Requisition Number31476BR
Qualifications
• 10+ years relevant work experience with a focus on data management

• Deep understanding of drug development and biopharmaceutical industry required

• Strong project management skills, and ability to effectively lead and collaborate with various business functions project management certified desirable

• High attention to detail including proven ability to manage multiple, competing priorities

• Experience overseeing outsourced clinical trials work

• Demonstrated ability to establish effective business relationships with external stakeholders, including implementing process change at a vendor

• Deep knowledge of clinical data management outsourcing with full-service, global CROs and FSPs

• Expertise in clinical program indications, end points, dataflow, data integrity, standards, and data quality

• Demonstrated ability to influence without authority

• Excellent written and oral communication skills
Education
• Bachelor's degree, preferably in a scientific discipline such as Statistics, Mathematics, Economics, Computer Science, IT, Biology, Social Science, etc.
About BiogenCorporate Overview

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis (MS), has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). Biogen also manufactures and commercializes biosimilars of advanced biologics. Our global organization of nearly 7,000 employees is committed to a single mission: making a meaningful difference in the lives of patients with few or no treatment options.

One of the pioneers in biotechnology, Biogen was founded in 1978 and today serves patients in nearly 90 countries. Our global headquarters and R&D operations are located in Cambridge, Massachusetts, with an international headquarters in Zug, Switzerland, world-class manufacturing facilities in Research Triangle Park, North Carolina, USA and Hillerod, Denmark, and affiliate locations around the world.

Our Science

We aspire to have the greatest impact on patients and science of any biotechnology company in the history of our industry. To us, that means creating novel medicines that benefit individuals and society, and bringing new scientific understanding to diseases for which there are no adequate treatments.

For nearly two decades Biogen has led in the research and development of new therapies to treat MS, including the most prescribed oral treatment in the world. Now our research is driving revolutionary new MS treatments with the goal of reversing or even repairing damage caused by the disease. We are now applying our neurological expertise to solve some of most challenging and complex diseases of the brain, including Alzheimer's disease, Parkinson's disease, and ALS. As we uncover new insights into human biology, Biogen is employing cutting-edge technologies to discover potential treatments for rare and genetic disorders.

Biogen is revolutionizing biologics manufacturing, developing the industry's most advanced plants and processes. This expertise is used to produce both original innovative therapies and biosimilars that expand patient access to lower-cost medicines.

Our Corporate Citizenship

The same intellectual discipline and passion that drives our science is reflected in our corporate citizenship, environmental sustainability, and commitment to diversity and inclusion. As a company, we are focused on improving science education and limiting the impact of our company on the environment. In 2015, we became a carbon neutral company and ranked first place on Newsweek's 2015 Green Rankings, and we are an industry leader on the Dow Jones Sustainability World Index. Biogen was named to Science's list of Top Employers of 2015 and in 2017 received a perfect score of 100 for the fourth consecutive year on the Human Rights Campaign (HRC) Corporate Equality Index, which also named Biogen as one of its Best Places to Work.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

Please be advised that all legitimate correspondence from a Biogen employee will come from "@biogen.com" email accounts.

About Biogen

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company's products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab) and FUMADERM (dimethylfumarate and monoethylfumarate salts). AVONEX is used in the treatment of relapsing forms of multiple sclerosis (MS). RITUXAN is used in the treatment of relapsed or refractory low-grade or follicular, CD20-positive, and B-cell, non-Hodgkin's lymphomas (B-cell NHLs). TYSABRI is approved for the treatment of relapsing forms of MS. FUMADERM acts as an immunomudulator. It also has product candidates, such as BG-12 (acquired with the purchase of Fumapharm), ANTI-CD80 antibody/(galiximab), ANTI-CD23 antibody/(lumiliximab), Ocrelizumab/(Humanized ANTI-CD20 Antibody) and Lixivaptan.In January 2007, the Company completed the acquisition of Syntonix Pharmaceuticals, Inc. (Source: 10-K)

This company profile was created by AfterCollege and is about Biogen. This page is not endorsed by or affiliated with Biogen. For questions regarding company profiles, please email: care@aftercollege.com.